Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECTA: Tadalafil for Prevention of Hypertensive Disorders of Pregnancy Recurrence
jRCTs041180121Completed
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of tadalafil in maternal hypertension (HDP) and preeclampsia. Primary endpoint: Recurrence rate of Hypertensive Disorders of Pregnancy. Started Apr 2018; status: completed.
02
Drugs
tadalafil
03
Conditions
maternal hypertension (HDP)preeclampsia
Beyond the preview
Go deeper on jRCTs041180121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180121.